← Leaderboards
Sean Alexander Misek
Michigan State University
$378,911
Attributed
$378,911
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $143.8K · FY2018–25$200K$150K$100K$50K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$378,911 · 3
By mechanism
F32$150,684 · 1
K99$143,788 · 1
F31$84,439 · 1
Top collaborators
No co-investigators on record.
Most similar at Michigan State University
Same institution · by research overlap
- Robert A Casero$11,306,418
- Geoffroy O Laumet$2,924,178
- Michelle M Martel$6,088,423
- Jes Asmussen$335,165
- Dean M Aslam$54,400
Others in their field
Other Emerging Leaders on “Resistance”
- John Damon Chodera · Sloan-Kettering Inst Can Research$56,843,703
- Urs Ochsner · Crestone, Inc.$40,390,611
- Ryan Cirz · Revagenix, Inc.$40,209,479
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Michael Dignam · National Institute Of Allergy And Infectious Diseases$30,845,607
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
Research focus
ResistancePreventCellsPathway InteractionsBraf GeneNew Therapeutic TargetMap Kinase GeneTumorAffectMutantIntegral Membrane ProteinDependenceInhibitorMemberGenomeExtracellularGenome-WideDna Sequence AlterationBindingEventGenesComplexChildhoodDose
Grant awards (5)
Genetic dependencies in KIAA1549-BRAF rearranged pediatric low-grade gliomas$143,788
K99 · FY2025 · CA · contact PI
Identifying genetic vulnerabilities in KIAA1549-BRAF mutant pediatric low-grade gliomas$78,892
F32 · FY2024 · CA · contact PI
Identifying genetic vulnerabilities in KIAA1549-BRAF mutant pediatric low-grade gliomas$71,792
F32 · FY2023 · CA · contact PI
Targeting Sox10-low cells in drug-resistant melanoma$39,915
F31 · FY2019 · CA · contact PI
Targeting Sox10-low cells in drug-resistant melanoma$44,524
F31 · FY2018 · CA · contact PI